Halama, B. (2014). Nanodose study of the CYP3A paradigm substrate midazolam to evaluate pharmacokinetic linearity of parent drug before and during CYP3A inhibition.
Chicago Style (17th ed.) CitationHalama, Birte. Nanodose Study of the CYP3A Paradigm Substrate Midazolam to Evaluate Pharmacokinetic Linearity of Parent Drug Before and During CYP3A Inhibition. 2014.
MLA (9th ed.) CitationHalama, Birte. Nanodose Study of the CYP3A Paradigm Substrate Midazolam to Evaluate Pharmacokinetic Linearity of Parent Drug Before and During CYP3A Inhibition. 2014.
Warning: These citations may not always be 100% accurate.